Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Keeling

Showing results (101-110 of 121) with videos related to

Pageof 13
Sort By:
Plos One|April 18, 2013
Attenuation of nonsense-mediated mRNA decay enhances in vivo nonsense suppressionKim M Keeling, Dan Wang, Yanying Dai, et al.
Molecular Cell|June 10, 2008
Distinct eRF3 requirements suggest alternate eRF1 conformations mediate peptide release during eukaryotic translation terminationHua Fan-Minogue, Ming Du, Andrey V Pisarev, et al.
Blood|October 19, 2006
Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' OrganisationPeter W Collins, Sybil Hirsch, Trevor P Baglin, et al.
Pulmonary Circulation|January 6, 2021
Rescue therapy with thrombolysis in patients with severe COVID-19-associated acute respiratory distress syndromeLaura C Price, Benjamin Garfield, Caroline Bleakley, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|April 4, 2023
The synthetic aminoglycoside ELX-02 induces readthrough of G550X-CFTR producing superfunctional protein that can be further enhanced by CFTR modulatorsJianguo Chen, Kari Thrasher, Lianwu Fu, et al.
Journal of Thrombosis and Haemostasis : JTH|June 29, 2004
The incidence of factor VIII and factor IX inhibitors in the hemophilia population of the UK and their effect on subsequent mortality, 1977-99S C Darby, D M Keeling, R J D Spooner, et al.
Thrombosis and Haemostasis|April 20, 2001
Genetic predisposition to bleeding during oral anticoagulant therapy: evidence for common founder mutations (FIXVal-10 and FIXThr-10) and an independent CpG hotspot mutation (FIXThr-10)J Oldenburg, K Kriz, W A Wuillemin, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 15, 2010
Variant CJD infection in the spleen of a neurologically asymptomatic UK adult patient with haemophiliaA Peden, L McCardle, M W Head, et al.
Biological Psychiatry|September 27, 2005
Brain-derived neurotrophic factor and autoantibodies to neural antigens in sera of children with autistic spectrum disorders, Landau-Kleffner syndrome, and epilepsyAnne M Connolly, Michael Chez, Elizabeth M Streif, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 17, 2004
Management of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors' OrganizationK J Pasi, P W Collins, D M Keeling, et al.
Pageof 13

Showing results (101-110 of 121) with videos related to

Sort By:
Pageof 13
Plos One|April 18, 2013
Attenuation of nonsense-mediated mRNA decay enhances in vivo nonsense suppressionKim M Keeling, Dan Wang, Yanying Dai, et al.
Molecular Cell|June 10, 2008
Distinct eRF3 requirements suggest alternate eRF1 conformations mediate peptide release during eukaryotic translation terminationHua Fan-Minogue, Ming Du, Andrey V Pisarev, et al.
Blood|October 19, 2006
Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' OrganisationPeter W Collins, Sybil Hirsch, Trevor P Baglin, et al.
Pulmonary Circulation|January 6, 2021
Rescue therapy with thrombolysis in patients with severe COVID-19-associated acute respiratory distress syndromeLaura C Price, Benjamin Garfield, Caroline Bleakley, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|April 4, 2023
The synthetic aminoglycoside ELX-02 induces readthrough of G550X-CFTR producing superfunctional protein that can be further enhanced by CFTR modulatorsJianguo Chen, Kari Thrasher, Lianwu Fu, et al.
Journal of Thrombosis and Haemostasis : JTH|June 29, 2004
The incidence of factor VIII and factor IX inhibitors in the hemophilia population of the UK and their effect on subsequent mortality, 1977-99S C Darby, D M Keeling, R J D Spooner, et al.
Thrombosis and Haemostasis|April 20, 2001
Genetic predisposition to bleeding during oral anticoagulant therapy: evidence for common founder mutations (FIXVal-10 and FIXThr-10) and an independent CpG hotspot mutation (FIXThr-10)J Oldenburg, K Kriz, W A Wuillemin, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 15, 2010
Variant CJD infection in the spleen of a neurologically asymptomatic UK adult patient with haemophiliaA Peden, L McCardle, M W Head, et al.
Biological Psychiatry|September 27, 2005
Brain-derived neurotrophic factor and autoantibodies to neural antigens in sera of children with autistic spectrum disorders, Landau-Kleffner syndrome, and epilepsyAnne M Connolly, Michael Chez, Elizabeth M Streif, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 17, 2004
Management of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors' OrganizationK J Pasi, P W Collins, D M Keeling, et al.
Pageof 13